AFP and hepatocellular carcinoma: Finally, the specificity and high expression of AFP in HCC has been exploited in the development of AFP-directed autologous SPEAR T cells, which have been tested in HLA-A∗02-selected patients with AFP-overexpressing HCC in the phase I setting.